Vor Biopharma Stock Z Score

VOR Stock  USD 0.88  0.07  7.64%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Vor Biopharma Piotroski F Score and Vor Biopharma Valuation analysis.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.
  
At this time, Vor Biopharma's Change In Working Capital is relatively stable compared to the past year. As of 03/04/2025, Long Term Debt To Capitalization is likely to grow to 0.17, while Capital Stock is likely to drop 5,985. At this time, Vor Biopharma's Total Other Income Expense Net is relatively stable compared to the past year. As of 03/04/2025, Cost Of Revenue is likely to grow to about 4 M, while Interest Expense is likely to drop slightly above 987.4 K.

Vor Biopharma Company Z Score Analysis

Vor Biopharma's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

Vor Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Vor Biopharma is extremely important. It helps to project a fair market value of Vor Stock properly, considering its historical fundamentals such as Z Score. Since Vor Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vor Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vor Biopharma's interrelated accounts and indicators.
1.00.90.82-0.49-0.860.740.920.95-0.340.99-0.040.990.240.720.920.78
1.00.890.81-0.54-0.830.740.890.96-0.331.0-0.061.00.240.690.90.74
0.90.890.69-0.25-0.940.510.850.91-0.620.89-0.30.880.330.550.950.86
0.820.810.69-0.46-0.760.850.790.66-0.340.80.350.8-0.310.820.750.66
-0.49-0.54-0.25-0.460.1-0.59-0.21-0.45-0.15-0.56-0.22-0.570.23-0.31-0.150.12
-0.86-0.83-0.94-0.760.1-0.57-0.92-0.790.6-0.820.09-0.81-0.16-0.71-0.96-0.92
0.740.740.510.85-0.59-0.570.680.51-0.280.730.610.73-0.270.890.530.42
0.920.890.850.79-0.21-0.920.680.81-0.390.880.070.860.20.840.950.91
0.950.960.910.66-0.45-0.790.510.81-0.290.96-0.340.960.440.470.890.73
-0.34-0.33-0.62-0.34-0.150.6-0.28-0.39-0.29-0.320.11-0.31-0.09-0.32-0.49-0.57
0.991.00.890.8-0.56-0.820.730.880.96-0.32-0.071.00.250.680.890.72
-0.04-0.06-0.30.35-0.220.090.610.07-0.340.11-0.07-0.07-0.710.59-0.2-0.17
0.991.00.880.8-0.57-0.810.730.860.96-0.311.0-0.070.240.670.880.7
0.240.240.33-0.310.23-0.16-0.270.20.44-0.090.25-0.710.24-0.210.310.31
0.720.690.550.82-0.31-0.710.890.840.47-0.320.680.590.67-0.210.650.63
0.920.90.950.75-0.15-0.960.530.950.89-0.490.89-0.20.880.310.650.95
0.780.740.860.660.12-0.920.420.910.73-0.570.72-0.170.70.310.630.95
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

As per the company's disclosures, Vor Biopharma has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Vor Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vor Biopharma's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vor Biopharma could also be used in its relative valuation, which is a method of valuing Vor Biopharma by comparing valuation metrics of similar companies.
Vor Biopharma is currently under evaluation in z score category among its peers.

Vor Biopharma Institutional Holders

Institutional Holdings refers to the ownership stake in Vor Biopharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vor Biopharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vor Biopharma's value.
Shares
Mccormack Advisors International2024-12-31
283.2 K
Millennium Management Llc2024-12-31
261.8 K
Citadel Advisors Llc2024-12-31
200.4 K
Exchange Traded Concepts, Llc2024-12-31
165.8 K
Two Sigma Investments Llc2024-12-31
163.1 K
Morgan Stanley - Brokerage Accounts2024-12-31
159.9 K
Northern Trust Corp2024-12-31
157.6 K
Bridgeway Capital Management, Llc2024-12-31
132.6 K
State Street Corp2024-12-31
115.9 K
Ra Capital Management, Llc2024-12-31
39.6 M
Fmr Inc2024-12-31
6.4 M

Vor Fundamentals

About Vor Biopharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Vor Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vor Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vor Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.